Journal article
Routine Spironolactone in Acute Myocardial Infarction
Abstract
BACKGROUND: Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial after myocardial infarction is uncertain.
METHODS: In this multicenter trial with a 2-by-2 factorial design, we randomly assigned patients with myocardial infarction who had undergone percutaneous coronary intervention to receive either …
Authors
Jolly SS; d’Entremont M-A; Pitt B; Lee SF; Mian R; Tyrwhitt J; Kedev S; Montalescot G; Cornel JH; Stanković G
Journal
The New England Journal of Medicine, Vol. 392, No. 7, pp. 643–652
Publisher
Massachusetts Medical Society
Publication Date
February 13, 2025
DOI
10.1056/nejmoa2405923
ISSN
0028-4793